VITAKEY, INC.

Stabilization of therapeutic microbes for inclusion in a liquid matrix for delivery to the intestines

VITAKEY, INC. is a company in national institute of general medical sciences based in WASHINGTON, DC, founded in 2020.

Profile

Project Summary/Abstract
Enteral feeding (EF) is an essential medical procedure used to supply nutrients directly to the
gastrointestinal (GI) tract of patients who are unable to eat independently. EF formula is often
purchased as a ready-to-use liquid that contains carbohydrates, protein, fats, and micronutrients
to ensure adequate nutritional benefit for the patient. Ninety three percent of EF formulas are
dosed simultaneously with antibiotics. Because of this, >60% of these patients will experience
antibiotic-associated diarrhea (AAD). AAD severely decreases nutrient absorption, hydration
status, and quality of life substantially for EF patients. There is currently no treatment for AAD,
as each antibiotic regimen prescribed to patients differs based on initial health status, and often
>30% of AAD patients further develop antibiotic-resistant Clostridium difficile infections after
prolonged antibiotic administration.
Probiotics offer a potential therapeutic strategy to counteract AAD, as probiotics have been
demonstrated to facilitate carbohydrate digestion, restore healthy microflora, and improve
intestinal barrier strength and nutrient absorption. Probiotics, however, are highly susceptible to
degradation due to shelf storage and upon oral consumption which has yielded conflicting
clinical results across multiple trials in the treatment of AAD. Additionally, EF patients are

As a business in national institute of general medical sciences, VITAKEY, INC. is listed here with the public details available about it.

WASHINGTON, DC is where the company is located.

Directory data places it at the SBIR/STTR stage.

The company reports a headcount in the 11-50 range.

Public records show total funding of about $1.4M.

Website: vitakey.com